Increasing incidence of lentigo maligna melanoma subtypes: Northern California and national trends 1990-2000

Journal of Investigative Dermatology

Volumn 125, Issue 4, 2005, Pages 685-691

  Swetter, Susan M ^a,b   Boldrick, Jennifer C ^b   Jung, Sandy Y ^b   Egbert, Barbara M ^a,b   Harvell, Jeff D ^c,d  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Bethesda Dermatopathology Laboratory   (United States)

Author keywords

Epidemiology; Histopathology; Incidence; Melanoma

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER SCREENING; CARCINOMA IN SITU; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; MALIGNANT LENTIGO; MELANOMA; PRIORITY JOURNAL; SUN EXPOSURE; INCIDENCE; REGISTER; SKIN TUMOR; TIME; UNITED STATES;

CALIFORNIA; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; INCIDENCE; REGISTRIES; SEER PROGRAM; SKIN NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 27744593062     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23852.x     Document Type: Article

References (66)

1. Ackerman AB: Malignant melanoma: A unifying concept. Human Pathol 11:591-595, 1980
2. Ackerman AB: Mythology and numerology in the sphere of melanoma. Cancer 88:491-496, 2000
3. Ackerman AB, David KM: A unifying concept of malignant melanoma: Biologic aspects. Human Pathol 17:438-442, 1986
4. Armstrong BK: Epidemiology of malignant melanoma: Intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 14:835-849, 1988
5. Arrington JH III, Reed RJ, Ichinose H, Krementz ET: Plantar lentiginous melanoma: A distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1:131-143, 1977
6. Balch CM, Soong S-j, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer staging system. J Clin Oncol 19:3622-3634, 2001
7. Barnhill RL, Mihm MJ: The histopathology of cutaneous malignant melanoma. Semin Diag Pathol 10:47-75, 1993
8. Bastian BC, Kashani-Sabet M, Hamm H, et al: Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60:1968-1973, 2000
9. Burton RC, Armstrong BK: Current melanoma epidemic: A nonmetastasizing form of melanoma? World J Surg 19:330-333, 1995
10. Carmichael VE, Wilson KS: Primary cutaneous malignant melanoma: Experience of the British Columbia Cancer Agency from 1972 to 1981. Can J Surg 35:589-596, 1992
11. Castel T, Baradad M, Castro J, et al: Primary malignant melanoma of the skin. Retrospective study of 375 cases. Clinical aspects and histology. Med Clin (Barcelona) 24:246-249, 1990
12. Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC: Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 41:945-949, 1999
13. Clark WH Jr, Ainsworth AM, Bernardino EA, Yan CH, Mihm CM Jr, Reed RJ: The developmental biology of primary human malignant melanomas. Semin Oncol 2:83-103, 1975
14. Clark WH Jr, Elder DE, Guerry D IV, et al: Model predicting survival in Stage I melanoma based on tumor progression. J Natl Cancer Inst 81:1893-1904, 1989
15. Clark WH Jr, From L, Bernardino EA, Mihm MC: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705-727, 1969
16. Clark WH Jr, Mihm MC: Lentigo maligna and lentigo-maligna melanoma. Am J Pathol 55:39-67, 1969
17. Cohen LM: Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 33:923-936, 1995
18. Cohen LM: What's new in lentigo maligna. Adv Dermatol 15:203-231, 1999
19. Coleman WP III, Loria PR, Reed RJ, Krementz ET: Acral lentiginous melanoma. Arch Dermatol 116:773-776, 1980
20. Corona R, Mele A, Amini M, et al: Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 14:1218-1223, 1996
21. Cox NH, Aitchison TC, Sirel JM, MacKie RM, Scottish Melanoma Group: Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Br J Cancer 73:940-944, 1996
22. Dennis LK: Analysis of the melanoma epidemic, both apparent and real: Data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135:275-280, 1999
23. Donnellan MJ, Seemayer T, Huvos AG, Mike V, Strong EW: Clinicopathologic study of cutaneous melanoma of the head and neck. Am J Surg 124:450-425, 1972
24. Dubow BE, Ackerman AB: Ideas in pathology; malignant melanoma in situ; the evolution of a concept. Mod Pathol 3:734-744, 1990
25. Elder DE, Murphy GF: Melanocytic tumors of the skin, fascicle 2. In: Rosai J, Sobin LH (eds). Atlas of Tumor Pathology, Third series. Washington, DC: Armed Forces Institute of Pathology, 1991: p 146-149
26. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC: Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada melanoma study. J Natl Cancer Inst 78:37-44, 1987
27. English DR, Heenan PJ, D'Arcy C, et al: Melanoma in Western Australia in 1980-81: Incidence and characteristics of histological types. Pathology 19:383-392, 1987
28. Flotte TJ, Mihm MC: Lentigo maligna and malignant melanoma in situ, lentigo maligna type. Hum Pathol 30:533-536, 1999
29. Geller AC, Miller DR, Annas GD, et al: Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288:1719-1720, 2002
30. Hall HI, Jamison P, Fulton JP, Clutter G, Roffers S, Parrish P: Reporting cutaneous melanoma to cancer registries in the United States. J Am Acad Dermatol 49:624-630, 2003
31. Hall HI, Miller DR, Rogers JD, Bewerse B: Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40:35-42, 1999
32. Heenan PJ, Matz LR, Blackwell JB, Kelsall GR, Sing A, ten Seldam RE, Holman CD: Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology 8:717-729, 1984
33. Hemminki K, Zhang H, Czene K: Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites. Int J Cancer 104:764-771, 2003
34. Holman CDJ, Armstrong BK: Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenetic types. J Natl Cancer Inst 73:75-82, 1984
35. Holman CDJ, Armstrong BK, Heenan PJ: A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 71:651-656, 1983
36. Ishihara K, Saida T, Yamamoto A: Japanese skin cancer society prognosis and statistical investigation committee: Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 6:109-116, 2001
37. Jelfs PL, Giles G, Shugg D, Coates M, Durling G, Fitzgerald P, Ring I: Cutaneous malignant melanoma in Australia, 1989. Med J Aust 161:182-187, 1994
38. Jones WO, Harman R, Ng AK, Shaw JHF: Incidence of malignant melanoma in Auckland, New Zealand: Highest rates in the world. World J Surg 23:732-735, 1999
39. Koh HK, Geller A, Miller DR, Clapp RW, Lew RA: Underreporting of cutaneous melanoma in cancer registries nationwide. J Am Acad Dermatol 27:1035-1036, 1992
40. Koh HK, Michalik E, Sober AJ, et al: Lentigo maligna melanoma has not better prognosis than other types of melanoma. J Clin Oncol 2:994-1001, 1984
41. Krieger N, Hiatt RA, Sagebiel RW, Clark WH Jr, Mihm MC Jr: Inter-observer variability among pathologists' evaluation of malignant melanoma; effects upon an analytic study. J Clin Epidemiol 47:897-902, 1994
42. Kuchelmeister C, Schaumburg-Lever G, Garbe C: Acral cutaneous melanoma in Caucasians: Clinical features, histopathology, and prognosis in 112 patients. Br J Dermatol 143:275-280, 2000
43. Kuno Y, Ishihara K, Yamazaki N, Mukai K: Clinical and pathological features of cutaneous malignant melanoma: A retrospective analysis of 124 Japanese patients. Jpn J Clin Oncol 26:144-151, 1996
44. Langford FPJ, Fisher SR, Molter DW, Seigler HF: Lentigo maligna melanoma of the head and neck. Laryngoscope 103:520-524, 1993
45. Langley RGB, Fitzpatrick TZ, Sober AJ: Clinical characteristics. In: Balch CM, Houghton AN, Sober AJ, Soong S-J (eds). Cutaneous Melanoma, 3rd edn. St Louis, MO: Quality Medical Publishing, 1998; p 81-101
46. Little JH, Holt J, David N: Changing epidemiology of malignant melanoma in Queensland. Med J Aust 1:66-69, 1980
47. Månsson-Brahme E, Johansson H, Larsson O, Rutqvist L, Ringborg U: Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol 41:138-146, 2002
48. McGovern VJ: The classification of melanoma and its relationship with prognosis. Pathology 2:85-98, 1970
49. McGovern VJ, Shaw HM, Milton GW, Farago GA: Is malignant melanoma arising in Hutchinson's melanotic freckle a separate disease entity? Histopathology 4:235-242, 1980
50. Merlino LA, Sullivan KJ, Whitaker DC, Lynch CF: The independent pathology laboratory as a reporting source for cutaneous melanoma in Iowa, 1977-1994. J Am Acad Dermatol 37:578-585, 1997
51. Miracco C, Santopietro R, Biagiolo M, et al: Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma. J Cutan Pathol 25:244-251, 1998
52. Newell GR, Sider JC, Bergfelt L, Kripke ML: Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res 48:5036-5041, 1988
53. O'Brien CJ, Coates AS, Peterson-Schaefer K, Shannon K, Thompson JF, Milton GW, McCarthy WH: Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 162:310-314, 1991
54. Oumeish OY: Epidemiology of primary cutaneous malignant melanoma in Jordan. Int J Dermatol 36:113-115, 1997
55. Popescu NA, Beard CM, Treacy PJ, Winkelmann RK, O'Brien PC, Kurland LT: Cutaneous malignant melanoma in Rochester, Minnesota: Trends in incidence and survivorship, 1950 through 1985. Mayo Clin Proc 65:1293-1302, 1990
56. Rigel DS: Malignant melanoma: Incidence issues and their effect on diagnosis and treatment in the 1990s. Mayo Clin Proc 72:367-371, 1997
57. Ringbord U, Afzelius LE, Lagerlof B, et al: Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: A report from the Swedish Melanoma Study Group. Cancer 71:751-758, 1993
58. Sagebiel RW: Unusual variants of melanoma: Fact or fiction? Semin Oncol 23:703-708, 1996
59. Sasaki Y, Niu C, Makino R, et al: BRAF point mutations in primary melanoma show difference prevalences by subtype. J Invest Dermatol 123:177-183, 2004
60. Seiffert J: Stat bite-underreporting of melanoma. J Natl Cancer Inst 84:289, 1992
61. Surveillance, Epidemiology, and End Results Program SEER*Stat Database: Incidence- SEER 9 Regs Public-Use, Nov 2002 Sub (1973-2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission; last accessed, February 20, 2005.
62. Tannous ZS, Lerner LH, Duncan LM, Mihm MC, Flotte TJ: Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type. Hum Pathol 31:705-708, 2000
63. Urist MM, Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ: Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 200:769-775, 1984
64. Vazquez-Botet M, Latoni D: Sanchez JL: Malignant melanoma in Puerto Rico. Bol Assoc Med P R 82:454-457, 1990
65. Weyers W, Euler M, Diaz-Cascajo C, Schill W-B, Bonczkowitz M: Classification of cutaneous malignant melanoma: A reassessment of histopathologic criteria for the distinction of different types. Cancer 86:288-299, 1999
66. Zippin C, Lum D, Hankey BF: Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76:2343-2350, 1995